A study of the electrophysiological effect of N-allyl-N- methyl-2- (3,4-methylenedioxyphenyl)-ethylamine (HF-Ⅴ-15) on cardiac tissues.

碩士 === 國立臺灣大學 === 藥理學研究所 === 84 === HF-Ⅴ-15 是合成小分子生物鹼,在大白鼠心臟組織具有稍微增加收縮力 及減慢心跳頻率的作用。本篇論文主要研究 HF-Ⅴ-15 在大白鼠及天竺鼠 心臟組織的電生理學,並研究其抗心律不整的作用機轉。 1、在大白鼠心 房及心室組織,HF-Ⅴ-15 (3∼30μM) 會使收縮力隨濃度增加而略為增強 ,並使右心房自發性跳動頻率減慢。 2、在離體天竺鼠心臟組織中,HF-...

Full description

Bibliographic Details
Main Authors: Lin,Wang-Jong, 林王忠
Other Authors: Su,Ming-Jai
Format: Others
Language:zh-TW
Published: 1996
Online Access:http://ndltd.ncl.edu.tw/handle/90768512568572360468
Description
Summary:碩士 === 國立臺灣大學 === 藥理學研究所 === 84 === HF-Ⅴ-15 是合成小分子生物鹼,在大白鼠心臟組織具有稍微增加收縮力 及減慢心跳頻率的作用。本篇論文主要研究 HF-Ⅴ-15 在大白鼠及天竺鼠 心臟組織的電生理學,並研究其抗心律不整的作用機轉。 1、在大白鼠心 房及心室組織,HF-Ⅴ-15 (3∼30μM) 會使收縮力隨濃度增加而略為增強 ,並使右心房自發性跳動頻率減慢。 2、在離體天竺鼠心臟組織中,HF- Ⅴ-15 能使 ouabain 誘發的心律不整,恢復為正常的跳動。 3、HF- Ⅴ-15 (30μM) 不影響 isoproterenol 的劑量反應曲線。 4、在大白鼠 心室細胞,10μM HF-Ⅴ-15 會延長動作電位,但不影響零期去極化速率 ,在 30μM 會使膜電位去極化,動作電位期間更加延長,並且顯著抑制 零期去極化速率。 5、利用全細胞膜電位鉗定法,HF-Ⅴ-15 (3∼100μ M) 會抑制鈉電流,使鈉電流穩定不活化曲線向負電位方向漂移,並使鈉 電流的恢復時間常數延長。 6、HF-Ⅴ-15 (3∼100μM) 會抑制大白鼠心 室細胞的鈣電流,其抑制作用在 1∼2 分鐘可達穩定,並使穩定不活化曲 線往負電位方向漂移,但不影響鈣管道恢復時間常數(fast component) 。 7、在大白鼠心室細胞,HF-Ⅴ-15 (3∼100μM) 會抑制瞬時外流鉀電 流,其抑制作用在 1∼2 分鐘可達穩定,其抑制程度會隨鉗定時間增加而 增加,並加速其不活化速率,延長恢復時間常數,使穩定不活化曲線向負 電位方向漂移。 8、在大白鼠心室細胞,HF-Ⅴ-15 (10∼100μM) 會抑制 內向整流鉀電流,在 100μM 內向流鉀電流的尖峰電流幾乎完全受抑制, 此內向整流鉀電流之值會隨超極化時間的延長而逐漸恢復。 9、HF- Ⅴ-15 (10∼100μM) 會抑制天竺鼠心室細胞的遲發性外流鉀電流。 10、 HF-Ⅴ-15 為作用快速的藥物,對上述各種電流的抑制較不具有選擇性, 其抗心律不整的能力來自於鈉、鉀及鈣離子管道的抑制。 HF-V-15 is a synthetic alkaloid found to have slight positive inotropic and negative chronotropic effect in rat cardiac tissues . The aim of the study was to examine the pharmacological effects of HF-Ⅴ-15 on rat and guinea pig cardiac tissues. The anti- arrhythmic effect of HF-Ⅴ-15 was also examined. 1.In rat ventricular cells, 10μM HF-Ⅴ-15 prolonged the action potential duration(APD) without any decrease in (dV/dt)max of the action potential. At 30μM, it caused depolarization and further increase in APD. 2.In rat ventricular cells HF-Ⅴ-15(3∼100μM) reduced the sodium current(INa) and shifted the steady-state inactivation curves of INa in negative direction and prolonged the recovery time constant of INa. 3.In rat ventricular cells HF-Ⅴ-15(3∼100μM) reduced the calcium current(ICa) and reach its steady state level within 1∼2 minute. The inhibition of ICa was associated with a negative shift of the steady-state inactivation curve. 4.In rat ventricular cells HF-Ⅴ-15(3∼100μM) reduced the transient outward curr ent(Ito) time-dependently. This inhibition of Ito reach its steady state level within 1∼2 minute. HF-Ⅴ-15 accelerated the inactivation rate of Ito and shifted the steady- state inactivation curve in negative direction. The recovery time from inactivation state was also prolonged. 5.HF-Ⅴ-15(10∼100μM ) inhibited the inward rectifier potassium current(IK1) in rat ventricular cells. The peak inward current through K1 channels was abolished completely by 100μM HF-Ⅴ-15. On hyperpolarization , partial relieve of complete IK1 block was observed. 6.HF-Ⅴ-15 (10∼100 μM) can inhibit delayed rectifier potassium current in guinea pig ventricular cells. HF-Ⅴ-15 is a fast onset drug. There is little selectivity of HF-Ⅴ-15 on INa, ICa, Ito and IK1. The antiarrhythmic effect of HF-Ⅴ-15 can be attributed to its multiple actions on ion channels.